Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
13.8342 EUR
12.37 B EUR
63.18 B EUR
29.02 M
About ROCHE I
Sector
CEO
Thomas Schinecker
Headquarters
Basel
Website
Founded
1896
ISIN
CH0012032113
FIGI
BBG000BNH221
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where RHO is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on HAN exchange ROCHE HLDG AG INH. SF 1 stocks are traded under the ticker RHO.
We've gathered analysts' opinions on ROCHE HLDG AG INH. SF 1 future price: according to them, RHO price has a max estimate of 468.65 EUR and a min estimate of 234.32 EUR. Watch RHO chart and read a more detailed ROCHE HLDG AG INH. SF 1 stock forecast: see what analysts think of ROCHE HLDG AG INH. SF 1 and suggest that you do with its stocks.
Yes, you can track ROCHE HLDG AG INH. SF 1 financials in yearly and quarterly reports right on TradingView.
ROCHE HLDG AG INH. SF 1 is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
RHO earnings for the last half-year are 10.62 EUR per share, whereas the estimation was 9.73 EUR, resulting in a 9.24% surprise. The estimated earnings for the next half-year are 9.00 EUR per share. See more details about ROCHE HLDG AG INH. SF 1 earnings.
ROCHE HLDG AG INH. SF 1 revenue for the last half-year amounts to 31.94 B EUR, despite the estimated figure of 30.75 B EUR. In the next half-year revenue is expected to reach 32.86 B EUR.
RHO net income for the last half-year is 6.50 B EUR, while the previous report showed 4.69 B EUR of net income which accounts for 38.48% change. Track more ROCHE HLDG AG INH. SF 1 financial stats to get the full picture.
Yes, RHO dividends are paid annually. The last dividend per share was 9.97 EUR. As of today, Dividend Yield (TTM)% is 3.56%. Tracking ROCHE HLDG AG INH. SF 1 dividends might help you take more informed decisions.
ROCHE HLDG AG INH. SF 1 dividend yield was 3.67% in 2023, and payout ratio reached 66.71%. The year before the numbers were 2.65% and 61.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 25, 2024, the company has 103.61 K employees. See our rating of the largest employees — is ROCHE HLDG AG INH. SF 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCHE HLDG AG INH. SF 1 EBITDA is 20.60 B EUR, and current EBITDA margin is 33.76%. See more stats in ROCHE HLDG AG INH. SF 1 financial statements.
Like other stocks, RHO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCHE HLDG AG INH. SF 1 stock right from TradingView charts — choose your broker and connect to your account.